2025 ICD-10-CM code N87.1

Moderate cervical dysplasia.Also known as Cervical intraepithelial neoplasia II [CIN II].

Code N87.1 should be used when a definitive diagnosis of moderate cervical dysplasia is confirmed histologically. It should not be used for abnormal Pap smear results or for suspected dysplasia without histological confirmation.

Medical necessity for treatment is based on the severity of the dysplasia. Moderate cervical dysplasia (CIN II) often warrants treatment to prevent it from progressing to a more severe form of dysplasia or cervical cancer.

Diagnosis and management of moderate cervical dysplasia falls under the purview of gynecologists and other healthcare providers specializing in women's health. This includes performing necessary diagnostic tests, such as Pap smears, colposcopy, and biopsies.Treatment options vary depending on the individual case and may involve close monitoring, cryotherapy, LEEP (loop electrosurgical excision procedure), or cone biopsy.

In simple words: Moderate dysplasia of the cervix refers to abnormal changes in the cells of the cervix, which is the lower part of the uterus.These changes are not cancer, but they can sometimes lead to cancer if left untreated.

Moderate cervical dysplasia, characterized by abnormal cell growth on the surface of the cervix. It is considered a precancerous condition, often referred to as CIN II.

Example 1: A 30-year-old female patient has an abnormal Pap smear result showing atypical squamous cells of undetermined significance (ASC-US).A subsequent colposcopy and biopsy reveal moderate cervical dysplasia (CIN II). The physician recommends a LEEP procedure to remove the abnormal cells., A routine Pap smear during a woman’s annual exam shows low-grade squamous intraepithelial lesion (LSIL). A colposcopy is performed and reveals an area of moderate dysplasia. A biopsy confirms CIN II., A 45-year-old woman presents with post-coital bleeding. A Pap smear and colposcopy/biopsy are performed, which reveals CIN II.

Documentation should include the findings from the pelvic exam, Pap smear results, colposcopy findings, and biopsy results.The size and location of the lesion should be documented, along with the chosen treatment and follow-up plan.

** Excludes1: abnormal results from cervical cytologic examination without histologic confirmation (R87.61-) carcinoma in situ of cervix uteri (D06.-) cervical intraepithelial neoplasia III [CIN III] (D06.-) HGSIL of cervix (R87.613) severe dysplasia of cervix uteri (D06.-)

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.